Biomarkers News, Articles | Today's Clinical Lab

The new technique could boost the accuracy of stool sample tests for IBD.

New Test Could Help Pinpoint IBD Diagnosis, Study Finds

University of Edinburgh

Researchers have developed a tool to measure the activity of a molecule linked to gut inflammation within fecal samples

MOBILion’s strategy is to integrate its HRIM technology across the mass spectrometry ecosystem, extending beyond proteomics into metabolomics, lipidomics, exposomics, and other high-value analytical markets.

MOBILion Systems Reports Proof-of-Concept Data Supporting a New Proteomics Approach

MOBILion Systems, Inc.

Peer-reviewed and collaborator studies indicate high-resolution ion mobility may address longstanding ion utilization limits in LC-MS proteomics workflows

This approach could make detecting Alzheimer’s disease easier and less invasive.

Dried Blood Spot Testing Shows Early Promise for Alzheimer’s Biomarkers

Springer Nature

Researchers report that dried blood spots can reliably measure p-tau217 and other Alzheimer’s biomarkers in a controlled research setting

Instead of relying solely on clinical endpoints over extended treatment periods, the research examined whether molecular signals could reveal pharmacodynamic activity within the first few days of treatment.

Rapid Transcriptomics Brings Actionable Data to Early-Phase Topical Trials

Stéphanie Légaré, PhD

Early transcriptomic readouts reveal pharmacodynamic activity in skin within days—a shift toward earlier molecular decision-making

The researchers are validating the model as a clinical test.

A New Way to Diagnose Deadly Lung Infections and Save Lives

University of California - San Francisco

Researchers at UC San Francisco have devised a method to identify pneumonia—using both genetic information and AI—that could curb the overuse of antibiotics

The study confirms previous preliminary results by comparing four biomarkers using an analysis method that can be applied in clinical settings.

Blood Test Reveals Prognosis After Cardiac Arrest

Lund University

Researchers compared four blood-based brain injury biomarkers across multiple centers to evaluate how reliably they estimate the extent of brain damage in unconscious patients after cardiac arrest

About 800,000 people have a heart attack every year in the US alone.

Can Better Diagnostics Lead to Improved Treatment for Cardiovascular Diseases?

Simon Williams, MBBS

From biomarkers to imaging, new lab-based diagnostics are transforming how cardiovascular risk is detected and managed

The Octave MSDA Test is the first and only clinically and analytically validated multi-analyte blood test that reports an MS disease activity score.

Nationwide Access to New Multi-Analyte Laboratory Test for Multiple Sclerosis

Quest Diagnostics, Octave Bioscience

Collaboration brings new hope for patients with multiple sclerosis through expanded access to a clinically validated multi-analyte blood test

Extracellular vesicles are nanometer-sized particles shed into body fluids, including blood and urine, that carry molecular information relevant to understanding, diagnosing, and treating cancer, degenerative diseases, and conditions in regenerative medicine.

Seed Funding Drives Development of Benchtop Exosome System for Precision Medicine

Hermes Biosciences

Hands-off isolation technology delivers higher yield and quality of extracellular vesicles, enabling reproducible workflows for clinical research and diagnostics

The study adds new evidence that brain-related biomarkers might play a useful role in monitoring recovery and guiding personalized care for young patients with concussion.

Blood Markers Linked to Post-Concussion Symptoms in Teens

Wolters Kluwer Health

Some concussion biomarkers show sex-specific differences

Biomarkers